BMRN : Analysis & Opinions
January 15, 2015These biotech firms want to revolutionize medicine. If successful, they may see high profits, but investing in these companies ...
November 12, 2013Among leading biotech and emerging pharmaceutical companies, the number of shares sold short in Alexion Pharmaceuticals ...
September 14, 2013Declining short interest in Alexion Pharmaceuticals (NASDAQ: PCYC) bucked the trend among leading biotech and emerging pharmaceutical ...
August 17, 2011In the wake of big pharma's patent cliff and slowing R&D spending, the biotech sector is looking good for investors.